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Pécs, Hungary, 7 Department of Medical Imaging, University of Pécs, Medical School, Pécs, Hungary
There is growing interest in the role of nerve-driven mechanisms in tumorigenesis and
tumor growth. Capsaicin-sensitive afferents have been previously shown to possess
antitumoral and immune-regulatory properties, the mechanism of which is currently poorly
understood. In this study, we have assessed the role of these terminals in the triple
negative 4T1 orthotopic mouse model of breast cancer. The ultrapotent capsaicin-
analogue resiniferatoxin (RTX) was used for the selective, systemic desensitization of
capsaicin-sensitive afferents. Growth and viability of orthotopically implanted 4T1 tumors
were measured by caliper, in vivo MRI, and bioluminescence imaging, while tumor
vascularity and protease enzyme activity were assessed using fluorescent in vivo
imaging. The levels of the neuropeptides Calcitonin Gene-Related Peptide (CGRP),
Substance P (SP), and somatostatin were measured from tumor tissue homogenates
using radioimmunoassay, while tumor structure and peritumoral inflammation were
evaluated by conventional use of CD31, CD45 and CD3 immunohistology. RTX-
pretreated mice demonstrated facilitated tumor growth in the early phase measured
using a caliper, which was coupled with increased tumor vascular leakage demonstrated
using fluorescent vascular imaging. The tumor size difference dissipated by day seven.
The MRI tumor volume was similar, while the intratumoral protease enzyme activity
measured by fluorescence imaging was also comparable in RTX-pretreated and non-
pretreated animals. Tumor viability or immunohistopathological profile was measured
using CD3, CD31, and CD45 stains and did not differ significantly from the non-pretreated
control group. Intratumoral somatostatin, CGRP, and SP levels were similar in both
groups. Our results underscore the beneficial, antitumoral properties of capsaicin sensitive
nerve terminals in this aggressive model of breast cancer, which is presumed to be due toJuly 2021 | Volume 11 | Article 6852971
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intratumoral neuropeptide levels indicates non-neural sources playing a substantial part
in their expression.Keywords: breast cancer, in vivo imaging, 4T1 breast cancer, vascular leakage, capsaicin sensitive sensory nervesINTRODUCTION
Breast cancer is the most commonmalignancy, and also the most
frequent cause of cancer-related death among women (1). Nearly
15% of all invasive breast cancers are triple-negative breast
cancers (TNBC), a very aggressive form (2, 3) in which
estrogen-, progesterone, and human epidermal growth factor
receptor 2 (HER2) expression is absent, which necessitates
finding novel targets to tackle TNBC. Since aggressive breast
cancers are highly dependent upon vascular supply and
neoangiogenesis, the 4T1 TNBC model (an aggressive mouse
breast cancer cell line derived from the mammary gland of the
BALB/c strain) is a vascularized tumor model (4). Due to poor
vascularization of rapidly growing 4T1 tumors these develop
spontaneous necrosis in the center of the tumor once reaching a
certain size (5).
Neural factors bear profound influence on breast cancer
growth and tumor cell proliferation, as summarized by a recent
comprehensive review (6). Prior studies have shown that increased
sympathetic activation facilitates metastatic potential in the 66cl4
murine mammary adenocarcinoma model (7). In the 4THMpc
murine model, vagotomy also facilitated distant metastasis
formation without influencing growth of the primary tumor,
while pharmacological activation of the vagus nerve decreases
metastatic potential coupled with an increased Substance P (SP)-
level in sensory nerve endings (8, 9). While several preclinical
studies demonstrated inhibitory vagal effects, multiple
retrospective clinical studies regarding cancer patients indicated
a stimulatory response. Thus, the net effect of parasympathetic
activation remains controversial (10). More recently, neural
activity and presence of nerve fibers have been confirmed
in vivo, in orthotopic 4T1 breast tumors, and evoked responses
were demonstrated when the cervical vagus nerve was electrically
stimulated, indicating a direct neural connection between the
brain and the mammary tumor. Intratumoral electrical activity
may likely be inhibited through the use of chemical
sympathectomy (11). Thus, neural regulation of the tumor
microenvironment has become an area of immense interest, as
recent evidence indicates tumor cells may commandeer and even
reactivate otherwise dormant nerve-driven pathways to further
facilitate their own growth (6).
Capsaicin-sensitive sensory nerves are selectively activated by
capsaicin, the pungent alkaloid of hot peppers. Capsaicin activates
the Transient Receptor Potential Vanilloid 1 (TRPV1) receptors,
which is responsible for its distinct taste (12). If frequently activated,
the receptors become desensitized towards further stimuli, which has
already been exploited as a therapeutical approach found in nasal
spray intended to treat migraine headaches, including the topical
analgesic treatment of rheumatoid arthritis and sensory neuropathy2
(12). Recently, the clinical applicability of capsaicin has also emerged
in oncology (13). Early on, the direct effect of capsaicin was debated
(14), more recent studies overwhelmingly demonstrated anticancer
effects, attributed to its pro-apoptotic, cell-cycle arrest-inducing, and
anti-angiogenic properties (15–18). Capsaicin can ablate TRPV1-
positive sensory neurons via Ca2+ overload. By a similar mechanism,
it may also kill tumor cells which express TRPV1. Nonetheless, it
remains to be seen, if tumors can indeed express TRPV1 at
sufficiently high concentrations to effectively enable this killing
effect. However, long-lasting effects of capsaicin and its analogues
exerted via desensitization of capsaicin-sensitive afferents have
manifold, indirect downstream effects. It has been demonstrated
that capsaicin-induced desensitization of peptidergic sensory nerve
terminals induces facilitated lung metastasis formation in the 4T1
breast cancer model. This was coupled with an increased number of
metastatic deposits in the heart, an otherwise uncommon site for
metastasis formation in the model. Interestingly, lower,
non-desensitizing doses of capsaicin were found to diminish lung
metastasis formation. Comprehensively, it has been postulated,
increased activation of capsaicin-sensitive afferents bears protective
effects, while their defunctionalization is detrimental, by removing the
homeostatic effects exerted by the neuropeptides released from them
(19). As afferents, capsaicin-sensitive peptidergic nerves transmit
inflammatory signals from the tumor to the central nervous
system. Furthermore, they also act as efferents, via neuropeptides
released locally from peripheral capsaicin-sensitive nerves and may
also influence tumor growth. Since many of these neuropeptides are
potently vasoactive, such as SP, Calcitonin Gene-Related Peptide
(CGRP), while others are anti-inflammatory (e.g., somatostatin), the
net effect of their actions can be considerably diverse. The sensory
nerves in the tumor microenvironment (stroma) are also known to
regulate neoangiogenesis in the tumor, and may play an important
role in tumor formation and progression. Capsaicinoids demonstrate
robust anti-angiogenic activity in mouse models (20). Vagal
afferentation was also found relevant in tumorigenesis and tumor
growth. It has been shown by several prospective clinical studies,
vagotomy increases the risk of developing lung or colorectal cancers
later on, and in vivo studies have demonstrated increased metastatic
potential in breast cancer following vagotomy. It has also been
demonstrated the sensory component of the vagal nerve also
contains capsaicin-sensitive afferents (8, 9, 21).
In this study, we aimed to characterize the role of capsaicin-
sensitive fibers in a mouse model of an orthotopically implanted,
triple negative 4T1 breast cancer model, using functional assessment
of tumor growth, in vivo imaging of tumor structure, vascularity, and
inflammatory enzyme activity. This was followed by ex vivo
evaluation of intratumoral levels of key neuropeptides contributing
to their vaso-, and immunoregulatory actions, including conventional
and immune-histopathological assessment of the tumor stroma. ThisJuly 2021 | Volume 11 | Article 685297
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dose capsaicin patches which function by sensory desensitization are
already in clinical use to relieve neuropathic pain (22). Thus, in this
study we aimed to determine breast cancer progression in mice after
defunctionalizing the capsaicin-sensitive peptidergic sensory nerves
by pretreatment with the ultrapotent capsaicin analog resiniferatoxin




Six-to-eight week old female BALB/c mice were bred and kept at
the Laboratory Animal House of the Department of Pharmacology
and Pharmacotherapy of the University of Pécs at 24-25°C, and
provided with standard rodent chow and water ad libitum under
12h dark/12h light cycles. The study was designed and conducted in
full accordance to the European legislation (directive 2010/63/EU)
and the Hungarian Government regulation (40/2013., II. 14.), in
reference to the protection of animals used for scientific purposes.
The project was approved by the Animal Welfare Committee of the
University of Pécs, and the National Scientific Ethical Committee
on Animal Experimentation of Hungary and licensed by the
Government Office of Baranya County (license No. BA02/2000-
32/2018). All efforts were made to keep the number of experimental
animals involved in the study at the necessary minimum.
Sensory Desensitization by
RTX Pretreatment
The involvement of capsaicin-sensitive neurons in tumor
progression was investigated with their long-lasting desensitization
using systemic treatment with high doses (10, 20, 70 and 100 µg/kg)
of the ultrapotent capsaicin analogue RTX (Sigma Aldrich, St. Louis,
MO, USA) injected subcutaneously over the span of four
consecutive days) three weeks prior to the inoculation (23). Mice
were simultaneously treated with a solution containing 4%
terbutaline–sulfate (AstraZeneca Ltd., Hungary, 4% theophylline-
ethylene diamin (Gedeon Richter Plc., Hungary) and 2% atropine–
sulfate (Egis Pharmaceuticals Plc., Hungary). The supporting drug
cocktail was utilized to diminish the acute respiratory side effects of
RTX-pretreatment (primarily bronchoconstriction and increased
mucus secretion). The supporting mixture has been shown to
reduce animal loss during desensitization with high dose capsaicin
and its analogs, including RTX (24, 25). RTX elicits permanent
opening of the TRPV1 ion channel receptors, and the resultant
intracellular cation influx induces long-lasting defunctionalization
of the whole sensory nerve terminals. Thus, it acts as a selective
neurotoxin, through which all TRPV1 receptor-expressing afferents
are deactivated. RTX has been shown to be several magnitudes (100
to 200 fold) more potent TRPV1 receptor agonist compared to
capsaicin. It was also proven that the loss of TRPV1 receptor
expression in the central nervous system is not reversible
following RTX-pretreatment (26, 27). As RTX-pretreated mice do
not display nocifensive reactions against TRPV1 agonist irritants
(e.g., capsaicin), these animals are colloquially referred to as
desensitized. The success of the sensory defunctionalization wasFrontiers in Oncology | www.frontiersin.org 3confirmed two weeks later by the absence of increased eye-wiping
behavior following 10 µl, 0.1% capsaicin drop compared to its
vehicle, indicating the peripheral defunctionalization of peptidergic
afferents. This test is a routinely used, well-established and widely
accepted technique (24, 28). In a prior study we have reported a
striking difference in the number of eye wipings in RTX-pretreated
mice (less than five per minute) compared to non-pretreated mice
(over 30 per minute) (23). As the 0.1% capsaicin solution elicits a
very profound nocifensive response in intact mice, in this study it
was only administered to RTX-pretreated animals.
Tumor Model
4T1 tumor cells (29) transfected with firefly luciferase were grown in
cell culture and processed for inoculation in vivo (5). The cell line was
maintained in DMEM (Gibco, Invitrogen) with 10% FBS,
1 mM l-glutamine, and penicillin/streptomycin (Gibco; Invitrogen)
and 0.25% trypsin/1mM EDTA (Life Technologies). Animals were
anesthetized by 100 mg Ketamine/10 mg Xylazine/kg (Calypsol® 50
mg/ml, Richter Gedeon, Budapest, Hungary; CP-Xylazin 2%,
Produlab Pharma, Raamsdonksveer, Netherlands) intra-peritoneally
(i.p.) 1x 106 4T1 cells in 50 µl 1:1 Matrigel®-PBS (Matrigel®
Basement Membrane Matrix, 354234, Corning®, NY, USA;
Phosphate Buffered Saline without Calcium and Magnesium #17-
516F, Lonza A. G., Basel, Switzerland) solution were subcutaneously
inoculated by a 50 ml Hamilton syringe (Hamilton Company, Reno,
Nevada, US). Inoculation was made orthotopically into the fourth
mammary gland’s fat pad in each mouse (30). Animals with the
largest, smallest or twin tumors were excluded from the study.
Tumor Size Measurements
Tumor size was measured daily using a digital caliper. Mice were
held in hand while measuring all three dimensions (p/6 x length,
x width and x height) of each tumor using the digital caliper with
0.01 mm precision (Mitutoyo, Kawasaki, Japan). The length was
measured along the longest linear dimension on the skin and the
width along the axis perpendicular to the longitudinal axis. The
height was measured at the tallest point of the tumor (31).
In Vivo Bioluminescence Imaging of Tumor
Growth and Viability
On days one, three and eight, following the inoculation of
bioluminescent tumor cells, the animals underwent in vivo
imaging using the IVIS Lumina III imaging system (PerkinElmer,
Waltham,MA, USA). The transfected 4T1 tumor cells express firefly
luciferase which produces bioluminescence following the addition of
its substrate (luciferin). In consideration of the imaging, a 15 mg/ml
solution of D−luciferin sodium salt (Gold Biotechnology, St. Louis,
MO, USA) in DPBS was administered i.p. in a 150 mg/kg dose.
Animals were anesthetized using ketamine-xylazine three minutes
following the administration of D-luciferin, and were imaged ten
minutes postinjection using the following settings: auto acquisition,
F/stop = 1 and Binning = 4. Data were analyzed using the Living
Image software (PerkinElmer). Regions of interest (ROI) were drawn
around the luminescent tumor signal automatically using identical
signal thresholds. Total radiance, a calibrated unit of the
luminescence (total photon flux per second), was calculated in
each ROI and used for further statistical analysis.July 2021 | Volume 11 | Article 685297
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Activity and Tumor Vascular Leakage
Increased levels of protease enzyme activity is a hallmark feature of
many tumors including breast cancer. Protease enzyme activity was
measured in vivo with the ProSense 680 (PerkinElmer) activable
fluorescent probe using the FMT 2000 fluorescence molecular
tomography system (PerkinElmer). ProSense is selectively activated
by several important, disease-associated proteases, such as Cathepsin
B, L, S and Plasmin, and was previously shown to be a robust tool in
monitoring their activity. ProSense is a fluorophore-conjugated graft
copolymer of polyethylene glycol and poly(Lys), and it is optically
silent under normal conditions. Upon selective enzymatic cleavage
the probe regains its fluorescent properties in the near-infrared range,
thus allowing selective detection of enzymatic activity (32). ProSense
was reconstituted in sterile 1xPBS. The probe was injected
intravenously (IV) under anesthesia through the retroorbital
venous plexus in a dose of two nmol/subject fully compliant to the
manufacturer’s recommended protocol. The mice were consequently
gently shaved and topically treated with hair removal cream under
anesthesia in the area surrounding their torso, in order to reduce
optical signal loss and scatter. Three-dimensional tomographic
imaging was performed twenty-four hours postinjection using the
680 nm laser channel of the device. In the 3-dimensional volumes of
interest representing the tumor tissue, the amount offluorophore was
automatically calculated through the use of TrueQuant software
(PerkinElmer) of the instrument in picomoles.
Tumor vascular leakiness was assessed with the AngioSense
680EX (PerkiElmer) fluorescent blood pool imaging probe in a
different set of mice. Upon IV injection, AngioSense remains
localized in the vasculature under normal conditions for up to four
hours, only showing accumulation in regions where vascular
structure is distorted, either due to pathological vessel leakage or
neoangiogenesis. The probe was injected (two nmol/subject in
1xPBS) and mice were prepared for imaging as formerly described.
Imaging was performed at twenty-four hours postinjection to
eliminate the biasing effect of any circulating tracer. The amount of
fluorophore in the tumor tissue was quantified as described earlier.
Magnetic Resonance Imaging of Tumor
Size and Internal Structure
The time course regarding tumor development was followed up
with an MRI from each treatment group on the second and on the
sixth days using a Bruker PharmaScan® (4.7 T) small-animal MRI
instrument. The imaging protocol was performed with a fast T2-
RARE (Rapid Acquisition with Relaxation Enhancement) method
(Thk: 1.00 mm, TR: 4000.00 ms, TE: 40.00 ms, matrix: 256x256).
Anesthesia was induced by 3% V/V of isoflurane (Medicus
Partner) in a gas mixture of 33% O2 and 66% N2O via rodent
facemask and maintained with 1–2% isoflurane controlled
by respiratory monitoring and gating system. Data were analyzed
using the 3D-Slicer open access software (33, 34).
Radioimmunoassay Measurement of
Neuropeptide Concentration in the 4T1
Tumor Tissue
CGRP, SP and somatostatin concentrations were determined
from homogenates of the 4T1 tumors. RIA was performed inFrontiers in Oncology | www.frontiersin.org 4phosphate buffer (pH 7.4, 50 mmol/L) containing sodium chloride
(100 mmol/L), sodium azide (0.05% w/v) and bovine serum albumin
(0.25%w/v). Polypropylene assay tubes contained samples or standard
peptides, tracer, antiserum and assay buffer. Standard, tracer and
antiserum were dissolved in an assay buffer. Samples measured
500 µL, whereas standard, tracer and antiserum were 100 µL each.
Tubes containing standard received 500 µL SIF solution to mimic the
effect of the sample solvent. Tubes were filled to 1000 µL with assay
buffer. Somatostatin-14, Tyr-a-CGRP23–37 and Lys3 Substance P
(Sigma-Aldrich, Hungary; Bachem, USA; and PerkinElmer, USA,
respectively) were used as a standard. The tracer was produced from
(Tyr1)-somatostatin-14 and Tyr-a-CGRP23–37 by incubating the
peptide with Na-125I and 1, 3, 4 and 6-tetrachloro-3a and 6a-
diphenyl-glycoluril. The mono-iodinated peptide was separated
during the reverse phase HPLC column. Tracer dilution was
adjusted to allocate 3000 cpm/100 µL. In the case of SP, 125I-Bolton
Hunter labeled Lys3 Substance P was used. Antiserum was used at
1:250000, 1:190000 and 1:320000 dilution in the case of SOM, CGRP
and SP, respectively. Assay tubes were incubated at 4° C for 48-72 h.
Antigen-bound and free peptides were separated by adding 100 µL of
a disperse system containing Norit-A (10%w/v), dextran (MW: 65-73
kDa, 1% w/v) and commercial fat-free milk powder (0.2% w/v) in
distilled water. Tubes were centrifuged at 4° C, 3000 g, for twenty
minutes. Pellets containing free peptides and supernatant containing
antibody-bound peptides were separated and radioactivity of both was
detected (GammaNZ-310, Hungary). A standard curvewas generated
by plotting the ratio of the activity of pellets and the activity of
supernatants of standard samples. Results are expressed as total SOM-
like, CGRP-like and SP-like immunoreactivity (fmol SOM-LI, fmol
GGRP-LI and fmol SP-LI) per mg tissue weight or per ml.
Histopathology and Immunohistochemistry
Procedures were performed as formerly described (35). Briefly, tumor
tissue samples were fixed in 10% formalin, dehydrated and
embedded in paraffin, followed up with serial sections (2.5 µm)
which were cut. Sections were dewaxed and rehydrated for
hematoxylin-eosin (H&E) staining and immunohistochemistry. In
consideration of antigen retrieval, heating was applied for twenty
minutes in Tris-EDTA (TE) buffer pH 9.0 (0.1 M Tris base and 0.01
M EDTA) using an Avair electric pressure cooker (ELLA 6 LUX
(D6K2A), Bitalon Ltd., Pécs, Hungary). and twenty minutes cooling
with open lid. Endogenous peroxidase blocking was performed using
3%H2O2 inmethanol for fifteenminutes. Non-specific proteins were
blocked for fifteen minutes in 3% bovine serum albumin (BSA, #82-
100-6, Millipore, Kankakee, Illinois, USA) diluted in 0.1 M Tris-
buffered saline (TBS, pH 7.4) containing 0.01% sodium azide.
Sections were incubated with primary antibodies diluted in 1%
BSA/TBS + TWEEN (TBST, pH 7.4) overnight (CD31), for sixty
(CD45), and ninety minutes (CD3) in a humidity chamber.
Peroxidase-conjugated anti-rabbit and anti-mouse IgGs (HISTOLS-
MR-T, micropolymer -30011.500T, Histopathology Ltd., Pécs,
Hungary) were used for forty minute incubations and the enzyme
activity was revealed with three each, 3’-diaminobenzidine (DAB)
chromogen/hydrogen peroxide kit (DAB Quanto-TA-060-QHDX-
Thermo Fischer Scientific, Waltham, MA, USA) under microscopic
control. All incubations were set to room temperature with the
samples washed between incubations in TBST buffer for 2 x 5 min.July 2021 | Volume 11 | Article 685297
Bencze et al. Capsaicin Sensitive Afferents Breast CancerH&E, CD3 (FLEX Polyclonal Rabbit Anti-Human CD3 RTU,
produced by DAKO), CD31 (clone D8V9E, produced by Cell
Signaling Technology) and CD45-immunostained (clone M0701,
produced by DAKO) slides were digitalized by Pannoramic Digital
Slide Scanner (3DHISTECH Ltd., Budapest, Hungary). Digitalized
slides were evaluated in CaseViewer image-analysis software
(3DHISTECH, Ltd.) with the QuantCenter-HistoQuant module.
Specific CD3, CD31 and the CD45 signal was masked according to
chromogene reaction intensity on the sections in the annotated area
(entire tumor or inflammatory ring area). The ratio of masked and
annotated area (relative mask area, rMA (%)) was used to estimate
CD3, CD31 and CD45 expression. CD31 expression was evaluated in
regards to the entire tumor annotated area. CD3 andCD45 expression
was evaluated in the annotated area of the inflammatory ring
regarding CD3 and CD45 stained slides, respectively. Inflammatory
ring/tumor area ratio was calculated on CD3 stained slides.
Statistical Analysis
All data are presented as means ± SEM, and were analyzed using the
statistical software package, GraphPad Prism v.7. (GraphPad
Software, Inc., San Diego, CA, USA). Results were analyzed by
two-way analysis of variance (ANOVA) followed by Sidak’s multiple
comparison test. Fluorescence in vivo imaging (AngioSense,
ProSense), RIA (CGRP, SP, and somatostatin) and
immunohistopathology data were analyzed first by unpaired t-test
and F-test. Due to the significantly different variance of the groups in
two datasets (AngioSense, SP-levels), these were further analyzed by
the modified Welch t-test. The experimental layout has been
summarized in Figure 1.RESULTS
Increased Tumor Burden in the
Early Phase of Tumor Growth in
Desensitized Mice
Following the orthotopic injection of the 4T1 tumor cells, rapid
growth was observed, with the mean tumor volume reachingFrontiers in Oncology | www.frontiersin.org 528.58 and 31.03 mm3 by day eight in non-pretreated and RTX-
pretreated animals, respectively. In the early phase of tumor
growth, particularly on day three and six, larger tumor volumes
were found using a digital caliper in desensitized mice when
compared with those in controls (4.55 vs. 1.72 and 21.25 vs.
17.87 mm3, p=0.0204 and 0.0375 respectively, Figure 2A), and to
a lesser degree, also on day seven and eight.
Direct volumetric T2-RARE MR imaging also demonstrated
rapid tumor growth, with the mean tumor volume increasing
from 23 and 16 mm3 to 49 and 51 mm3 in non-pretreated and
desensitized mice respectively between day two and six.
However, no significant difference in tumor volume could be
observed between the groups on MRI (Figures 2B, C).
4T1 Tumor Cell Viability and Growth
Measured by Bioluminescence
Is Not Significantly Different in
Desensitized Mice
Immediately twenty-four hours following the inoculation of the
4T1 cells, the in vivo luciferase bioimaging clearly demonstrated
the viability of cancer cells, confirming the success of the
orthotopic implantation. By day three, the bioluminescence
signal strength reflecting the viable cancer cells increased
significantly to nearly three to fourfold, which was followed by
an additional increase, approaching tenfold, in luciferase
luminescence by day eight. However, no significant difference
could be observed between the desensitized and control groups
(Figures 3A, B).
Similar Protease Activity, Yet Increased
Tumor Vascular Leakage Measured
Using Fluorescence In Vivo Imaging
in RTX-Pretreated Animals
Protease activity within the 4T1 tumors was measured by the
enzyme-activatable fluorescence probe ProSense on day seven
following inoculation. 4T1 tumors demonstrated robust and
specific enzyme activity at this point in both RTX-pretreated
and control animals. The protease activity tended to be greater inFIGURE 1 | Summary of the experimental design and timeline including the timing of the resiniferatoxin (RTX) pretreatment, inoculation of tumor cells (4T1), tumor
size measurements by caliper, MRI, as well as in vivo luminescence and fluorescence imaging by IVIS and FMT.July 2021 | Volume 11 | Article 685297
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(Figures 4A, C).
Tumor vascularity and leakage were also measured using the
AngioSense fluorescent tracer on day seven. Since the measurement
was carried out 24 hours postinjection, the fluorescence signal
observed at this time point is representative regarding the
retained tracer due to the enhanced permeability and retention
effect characteristic of malignant tumors including breast cancer.
The vascular signal was significantly increased in desensitized mice
compared with their non-pretreated controls (mean tracer amount
in tumors 154.8 vs. 84.9 pmols, p=0.039) indicating increased tumor
vessel leakage (Figures 4B, D).No Difference in the Intratumoral
Concentration of the Neuropeptides
CGRP, Somatostatin and SP in
Desensitized Mice
Neuropeptides measured by RIA from tumor tissue homogenates
obtained at the end of the experiment revealed no significant
differences in the concentration of the proinflammatory and
vasoactive CGRP, and the anti-inflammatory somatostatin
between desensitized mice and the non-pretreated control
group (Figures 5A, B). The concentration of the predominantlyFrontiers in Oncology | www.frontiersin.org 6proinflammatory, pronociceptive, and vasoactive neuropeptide
SP was also not significantly lower in RTX-pretreated mice
compared to their controls (50.9 vs. 82.2 fmol/mg tumor
tissue; Figure 5C).Unaltered Levels of CD31, CD3, and
CD45 Immunoreactivity in the 4T1
Breast Tumor Tissue in
Desensitized Mice
Considering the observed in vivo differences in intratumoral
vascular leakage, CD3, CD31, and CD45 were selected as
markers to further assess endothelial changes and immune-cell
response (36–38). Semi-automated quantification of CD31
immunohistology within the annotated area of the tumor
tissue harvested at the end of the experiment was not
significantly different in RTX-pretreated and non-pretreated
control animals (1.449 vs 1.599 relative mask area (rMA) (%);
Figures 6A, B, D). An inflammatory ring in the area adjacent to
the tumors appeared in both the non-pretreated and RTX-
pretreated group following H&E staining.
The vast majority of inflammatory cells in the rings appeared
to be small cells with round nuclei, identified as T-lymphocytes
(not shown). CD45 expression analysis also showed no differenceA B
C
FIGURE 2 | Moderately increased tumor volume in RTX pretreated mice in the early phase postimplantation. (A) Primary 4T1 tumor volume (mm3) and growth in BALB/c
mice (n = 10-14 per group, log10 scale), measured using a digital caliper. (B) Tumor size measurement (mm
3) evaluated by high resolution MRI. (n = 10). (C) Representative
image of tumor structure (3D volume rendering and one T2-weighted slice in the coronal plane). Tumor volumes were calculated via 3D rendering and measuring. Data were
calculated with 3D-Slicer 4.10.2, *p < 0.05 vs. non-pretreated, #p < 0.05, ##p < 0.01, ###p < 0.001 vs. initial measurement of the respective group.July 2021 | Volume 11 | Article 685297
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Figures 6C, E).
A more detailed analysis performed through anti-CD3
immunohistochemistry however, revealed no difference
between RTX-pretreated and non-pretreated tumors: The
extent of the inflammatory rings (inflammatory ring area/
tumor area: 0.49 vs. 0.42 ring/tumor area; Figures 7A, B) and
quantification of CD3+ (57.04 vs. 54.60 rMA(%); Figures 7C, D)
in the inflammatory rings were similar.Frontiers in Oncology | www.frontiersin.org 7DISCUSSION
In consideration of this model of 4T1 orthotopic, triple negative
breast cancer, we found divergent effects of RTX-induced
desensitization of the capsaicin sensitive afferents. First, we
demonstrated in the early period following tumor tissue
implantation, growth was accelerated in RTX-pretreated mice;
however, this difference subsides in the later phase. The
facilitated tumor growth is accompanied by increased
intratumoral vascular leakage, while inflammatory enzyme
activity does not significantly differ. Notably, tumor expansion
measured through the use of bioluminescence imaging is also
comparable in desensitized and control mice. CGRP,
somatostatin, and SP levels measured in the tumor tissue
showed no significant difference between the groups.
Histological tumor tissue morphology, including CD31, CD3
and CD45 expression measured by immunohistochemistry, did
not differ significantly between the groups, indicating tumor
architecture itself is not directly influenced by RTX-
pretreatment. The interesting discrepancy between the tumor
size measured through the use of a caliper and MRI can be
attributed to the fact the latter method quantified tumor volume,
yet not the peritumoral edema, which is often significant in
aggressive forms of breast cancer (39).
The increased early growth and vascular leakage in the
orthotopically implanted 4T1 tumors of desensitized mice
indicates a beneficial regulatory effect of capsaicin-sensitive
sensory nerves. Many neuropeptides released from these
terminals (including CGRP and SP) are amongst the most
potent endogenous vasoactive mediators, and can induce
vasodilation, increased vascular leakage and increased efflux of
plasma proteins and leukocytes (40–42). From a practical
viewpoint, the observed increased intratumoral leakage following
desensitization is a Janus-faced feature. Hyperpermeability of
tumor vessels can hinder effective drug delivery, yet can also
facilitate leakage and accumulation of large molecule drugs which
cannot readily leave normal vasculature, resulting in their selective
accumulation in the tumor tissue (43). Our results are in
agreement to a prior study in which pretreatment with the less
potent TRPV1-agonist capsaicin facilitated the metastasis of 4T1
tumor in the lung and heart, while in lower, non-desensitizing
doses, it decreased the frequency of lung metastases (19). In this
experiment, growth of the primary implanted tumor was
unaffected by capsaicin-induced desensitization. However, the
authors did not evaluate tumor growth in the very early
phase postimplantation.
Among the neuropeptides released by capsaicin-sensitive
afferents, SP was shown to facilitate breast cancer growth and
metastasis formation (44). In our model, SP levels did not change
significantly, despite increased early phase tumor growth and
vascular leakage. The unaltered CGRP, SP and somatostatin
levels observed in the tumor tissue of desensitized mice
indicate significant non-neural sources of these mediators. The
absence of the beneficial immuno-regulatory effect of sensory
neuropeptides released by sensory nerve endings had been
previously suggested as a detrimental factor in cancer, since SP
at low levels can increase immunoglobulin and cytokineA
B
FIGURE 3 | Similar 4T1 tumor cell viability and growth measured by
bioluminescence imaging in desensitized mice. (A) Tumor viability measured
as the luminescence (total flux [p/s]) of luciferase transfected 4T1 tumor cells
non-pretreated and RTX pretreated groups (n=10-14/group).
(B) Representative in vivo bioluminescence images shown as pseudocolor
representation of radiance [p/sec/cm2/sr] overlaid onto simultaneously
acquired grayscale photographs of the subjects. The color scale indicates the
level of luminescence corresponding to each color on the images, #p < 0.05,
###p < 0.001 vs. initial measurement of the respective group.July 2021 | Volume 11 | Article 685297
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proliferation (19, 45–48). Furthermore, regarding metastatic 4T1
breast cancer, it was discovered that SP is capable of
counteracting tumor-induced endothelial dysfunction (49). In a
prior study regarding lung metastasis formation in breast cancer,
it was shown that sensory vagal activity significantly diminishes
both SP levels and the metastatic burden (8). A later study
showed that drug-induced vagal activity also decreases the
metastatic burden and metastasis formation in the 4THM
breast cancer model (9). Therefore, it has been proposed,
functional capsaicin-sensitive afferents constitute a gatekeeper
mechanism which limits metastatic propagation in breast cancer
via local neuropeptide release (50). Furthermore, it was found
that capsaicin-induced desensitization results in a less favorable
gene expression profile in breast cancer, potentially due to the
diminished activation of certain genes pivoting towards
inhibition of cancer growth (50–52). However, it has been
shown that tumor cells also express SP, and SP levels are
elevated in breast cancer due to the lacking inhibitory effect of
the RE1-silencing transcription factor (REST) in SP-expression
(53). Since REST is downregulated in breast cancer, this results in
an increased intratumoral SP-level. Considering the antitumoral
effects of SP at lower levels, it has been proposed that intact SPFrontiers in Oncology | www.frontiersin.org 8stimulates tumorigenesis, while its bioactive fragments resulting
from enzymatic hydrolysis can suppress tumor growth (54, 55).
While capsaicin-sensitive afferents are a pivotal source of CGRP,
expression of this vasoactive neuropeptide was also not
significantly lower in desensitized animals. However, it has
been shown, breast cancer cells themselves strongly express
CGRP (56). Thus, in conclusion, this non-neural source of the
peptide maintains its concentration within the tumor tissue. In a
similar manner, while somatostatin is released by sensory nerve
endings in significant quantities, the gut and central nervous
system are considered to be their primary source in rodents (57).
Comprehensively, our findings indicate that intratumoral
neuropeptide levels are primarily influenced by non-neural
sources. Further studies using both neuropeptide gene-deficient
mice and tumor cell lines are warranted to differentiate how
tumoral and systemic, yet non-neural neuropeptide expression,
contributes to their production and biologic action in
breast cancer.
Capsaicin sensitive-sensory nerves influence tumor growth,
and vascular permeability in this orthotopic model of 4T1 breast
cancer. The increased vascular leakage observed within the
tumors of desensitized mice is likely due to the imbalance of
local neurogenic vasoregulation, which in turn, can facilitateA B
DC
FIGURE 4 | Increased intratumoral vascular leakage in RTX pretreated animals. (A, B) Fluorescent molecular tomography (FMT) imaging of protease enzyme activity
(ProSense 680) and tumor vascular leakage (AngioSense 680EX) (n = 5-7/group) measured as the amount of fluorescent tracer in the tumors (pmol) on day seven
following inoculation. (C, D) Representative FMT-images shown as pseudocolor representations of the amount of fluorophore, overlaid onto grayscale silhouette
images of the subjects, *p < 0.05 vs. non-pretreated.July 2021 | Volume 11 | Article 685297
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FIGURE 5 | Intratumoral concentrations of the neuropeptides Calcitonin Gene-Related Peptide (CGRP), Somatostatin, and Substance P (SP) measured by
radioimmunoassay are not significantly altered by RTX-pretreatment. Intratumoral neuropeptide concentrations (fmol/mg) of (A) CGRP, (B) Somatostatin, (C) SP.
The min to max values are demonstrated with all data points.Frontiers in Oncology | www.frontiersin.org July 2021 | Volume 11 | Article 6852979
Bencze et al. Capsaicin Sensitive Afferents Breast Cancertumor vascular bed disruption. On the other hand, intratumoral
protease expression was also not significantly different in our
experiment, accompanied by a maintained level of neuropeptides
in the tumor tissue. Finally, as demonstrated by the
histopathological analysis long-term tumor growth, cellular
profile and viability were not significantly influenced by the
desensitization of these nerve terminals.
Admittedly, our study has several limitations. Most
importantly, only the levels of selected key neuropeptides were
measured, which was dictated by the limited amount of tumor
tissue available for ex vivo radioimmunoassay. Furthermore, theFrontiers in Oncology | www.frontiersin.org 10molecular underpinnings of the observed increased intratumoral
vascular leakage in RTX-pretreated mice remain unclear.
Additionally, the MRI protocol used is ill-suited for measuring
the peritumoral edema, which may explain the diverging results
compared to the tumor size measurements obtained through the
use of a caliper.
In summary, capsaicin-sensitive sensory nerves exert
important and beneficial vasoregulatory effects on the tumor
tissue, which reduces pathological vascular hyperpermeability
and thereby early phase tumor growth (and potentially




FIGURE 6 | No significant difference observed in in CD31 and CD45 immunoreactivity of the 4T1 tumor tissue in RTX-pretreated mice. (A) Representative H&E and
(B) anti-CD31 stained histopathological slides with high magnification (23x). (C) Representative anti-CD45 stained slides with high (23x) magnification. (D) CD31
expression measured by quantitative immunohistochemistry (relative mask area %). (E) CD45 expression measured by quantitative immunohistochemistry (relative
mask area %).July 2021 | Volume 11 | Article 685297
Bencze et al. Capsaicin Sensitive Afferents Breast Cancerhas no direct effect on tumor structure and cellular viability.
These findings, along with prior evidence underline capsaicin-
sensitive afferents and functioning sensory innervation of the
tumor microenvironment possess homeostatic and antitumoral
properties. Therefore, caution must be maintained while
pharmacologically targeting these nerve terminals (e.g., use of
TRPV1 antagonist analgesic candidates), in order to avoid
potential detrimental effects in facilitating tumorigenesis. On a
separate note, the increased intratumoral leakage can also
significantly influence effective drug delivery into the tissue
and can facilitate selective accumulation of large molecule
therapeutics within the tumor.DATA AVAILABILITY STATEMENT
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